Biomedicines, Vol. 11, Pages 1500: Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies

Biomedicines, Vol. 11, Pages 1500: Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies

Biomedicines doi: 10.3390/biomedicines11051500

Authors: Yafei Huang Bingying Zhou

Mitochondria are the main site of intracellular synthesis of ATP, which provides energy for various physiological activities of the cell. Cardiomyocytes have a high density of mitochondria and mitochondrial damage is present in a variety of cardiovascular diseases. In this paper, we describe mitochondrial damage in mitochondrial cardiomyopathy, congenital heart disease, coronary heart disease, myocardial ischemia–reperfusion injury, heart failure, and drug-induced cardiotoxicity, in the context of the key roles of mitochondria in cardiac development and homeostasis. Finally, we discuss the main current therapeutic strategies aimed at alleviating mitochondrial impairment-related cardiac dysfunction, including pharmacological strategies, gene therapy, mitochondrial replacement therapy, and mitochondrial transplantation. It is hoped that this will provide new ideas for the treatment of cardiovascular diseases.